Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

NCT05930275 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
1200
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie